High glucose may decrease the innate immune through TLRs in cornea epithelium

Molecular Vision

Volumn 17, Issue , 2011, Pages 3384-3391

  Ni, Hailong ^a   Yan, Xiaoran ^b   Lin, Zhenyun ^c   Jin, Xiuming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERLEUKIN 6; INTERLEUKIN 8; MANNITOL; MESSENGER RNA; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOKINE RELEASE; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOMODULATION; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; OSMOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANTIBODIES, NEUTRALIZING; CELLS, CULTURED; CORNEA; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GENE EXPRESSION; GLUCOSE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; INTERLEUKIN-8; MANNITOL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84856205533     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332:1210-7. [PMID: 7700316]
2. Kaji Y. Prevention of diabetic keratopathy. Br J Ophthalmol 2005; 89:254-5. [PMID: 15722297]
3. Kabosova A, Kramerov AA, Aoki AM, Murphy G, Zieske JD, Ljubimov AV. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp Eye Res 2003; 77:211-7. [PMID: 12873452]
4. Inoue K, Okugawa K, Amano S, Oshika T, Takamura E, Egami F, Umizu G, Aikawa K, Kato S. Blinking and superficial punctate keratopathy in patients with diabetes mellitus. Eye (Lond) 2005; 19:418-21. [PMID: 15286669]
5. Rehany U, Ishii Y, Lahav M, Rumelt S. Ultrastructural changes in corneas of diabetic patients: an electron-microscopy study. Cornea 2000; 19:534-8. [PMID: 10928773]
6. Saini JS, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. Can J Ophthalmol 1995; 30:142-6. [PMID: 7627899]
7. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981; 79:180-99. [PMID: 7342400]
8. Pflugfelder SC. Is autologous serum a tonic for the ailing corneal epithelium? Am J Ophthalmol 2006; 142:316-7. [PMID: 16876515]
9. Kumar A, Yu FS. Toll-Like Receptors and Corneal Innate Immunity. Curr Mol Med 2006; 6:327-37. [PMID: 16712478]
10. Zhang J, Xu K, Ambati B, Yu FS. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthalmol Vis Sci 2003; 44:4247-54. [PMID: 14507868]
11. Kumar A, Zhang J, Yu FS. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci 2004; 45:3513-22. [PMID: 15452057]
12. Song PI, Abraham TA, Park Y, Zivony AS, Harten B, Edelhauser HF, Ward SL, Armstrong CA, Ansel JC. The expression of functional LPS receptor proteins CD14 and tolllike receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci 2001; 42:2867-77. [PMID: 11687531]
13. Johnson AC, Heinzel FP, Diaconu E. Activation of Toll-Like Receptor (TLR)2, TLR4, and TLR9 in the Mammalian Cornea Induces MyD88-Dependent Corneal Inflammation. Invest Ophthalmol Vis Sci 2005; 46:589-95. [PMID: 15671286]
14. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91:295-8. [PMID: 9363937]
15. Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature 2004; 430:257-63. [PMID: 15241424]
16. Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, Grafenstein H, Hong SC, McInerney MF. Dysregulated Toll-like receptor expression and signaling in bone marrowderived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 2006; 18:1101-13. [PMID: 16728431]
17. Kim HS, Han MS, Chung KW, Kim S, Kim E, Kim MJ, Jang E, Lee HA, Youn J, Akira S, Lee MS. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007; 27:321-33. [PMID: 17707128]
18. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008; 93:578-83. [PMID: 18029454]
19. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292:E740-7. [PMID: 17090751]
20. Yin J, Yu FS. LL-37 via EGFR Transactivation to Promote High Glucose-Attenuated Epithelial Wound Healing in Organ-Cultured Corneas. Invest Ophthalmol Vis Sci 2010; 51:1891-7. [PMID: 19797203]
21. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105:1158-61. [PMID: 11889007]
22. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003; 112:1234-43. [PMID: 14561697]
23. Yang X, Coriolan D, Murthy V, Schultz K, Golenbock DT, Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol 2005; 289:H1069-76. [PMID: 15863460]
24. Kaisho T, Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 2003; 3:373-85. [PMID: 12776992]
25. Miller LS, Sorensen OE, Liu PT, Jalian HR, Eshtiaghpour D, Behmanesh BE, Chung W, Starner TD, Kim J, Sieling PA, Ganz T, Modlin RL. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005; 174:6137-43. [PMID: 15879109]
26. Saillan-Barreau C, Cousin B, Andre M, Villena P, Casteilla L, Penicaud L. Human adipose cells as candidates in defense and tissue remodeling phenomena. Biochem Biophys Res Commun 2003; 309:502-5. [PMID: 12963017]
27. Bès-Houtmann S, Roche R, Hoareau L, Gonthier MP, Festy F, Caillens H, Gasque P, Lefebvre d'Hellencourt C, Cesari M. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 2007; 127:131-7. [PMID: 16988837]
28. Barton GM, Medzhitov R. Toll-Like receptor signaling pathways. Science 2003; 300:1524-5. [PMID: 12791976]
29. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14:129-35. [PMID: 11790543]
30. Jin X, Lin Z, Xie X. The delayed response of TLRs may relate to P. aeruginosa keratitis exacerbates rapidly at the early stage of infection. Eur J Clin Microbiol Infect Dis 2010; 29:231-8. [PMID: 20012880]
31. Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, Nishida T. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci 2005; 46:114-20. [PMID: 15623762]
32. Ueta M, Hamuro J, Kiyono H, Kinoshita S. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun 2005; 331:285-94. [PMID: 15845391]
33. Jin X, Qin Q, Tu L, Zhou X, Lin Y, Qu J. Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Mol Vis 2007; 13:1953-61. [PMID: 17982419]
34. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392-6. [PMID: 11067888]
35. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-8. [PMID: 9851930]
36. Medzhitov R, Preston-Hurlburt P, Janeway CA. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394-7. [PMID: 9237759]
37. Homma T, Kato A, Hashimoto N, Batchelor J, Yoshikawa M, Imai S, Wakiguchi H, Saito H, Matsumoto K. Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 2004; 31:463-9. [PMID: 15242847]
38. Sakai A, Han J, Cato AC, Akira S, Li JD. Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol Biol 2004; 5:2. [PMID: 15125785]
39. Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem 2002; 277:47444-50. [PMID: 12356755]
40. Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 2004; 24:4743-56. [PMID: 15143169]
41. Rozkova D, Horvath R, Bartunkova J, Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin Immunol 2006; 120:260-71. [PMID: 16765091]
42. Eicher SD, McMunn KA, Hammon HM, Donkin SS. Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves. Vet Immunol Immunopathol 2004; 98:115-25. [PMID: 15010221]